1 Neuroleptic Market Overview 1.1 Neuroleptic Product Scope 1.2 Neuroleptic Segment by Type 1.2.1 Global Neuroleptic Sales by Type (2020-2026) 1.2.2 Droperidol 1.2.3 Midazolam 1.3 Neuroleptic Segment by Application 1.3.1 Global Neuroleptic Sales Comparison by Application (2020-2026) 1.3.2 Medical Care 1.3.3 Scientific Research 1.3.4 Others 1.4 Neuroleptic Market Estimates and Forecasts (2015-2026) 1.4.1 Global Neuroleptic Sales Growth Rate (2015-2026) 1.4.2 Global Neuroleptic Revenue and Growth Rate (2015-2026) 1.4.3 Global Neuroleptic Price Trends (2015-2026) 2 Neuroleptic Estimate and Forecast by Region 2.1 Global Neuroleptic Market Size by Region: 2015 VS 2020 VS 2026 2.2 Global Neuroleptic Retrospective Market Scenario by Region (2015-2020) 2.2.1 Global Neuroleptic Sales Market Share by Region (2015-2020) 2.2.2 Global Neuroleptic Revenue Market Share by Region (2015-2020) 2.3 Global Neuroleptic Market Estimates and Forecasts by Region (2021-2026) 2.3.1 Global Neuroleptic Sales Estimates and Forecasts by Region (2021-2026) 2.3.2 Global Neuroleptic Revenue Forecast by Region (2021-2026) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 United States Neuroleptic Estimates and Projections (2015-2026) 2.4.2 Europe Neuroleptic Estimates and Projections (2015-2026) 2.4.3 China Neuroleptic Estimates and Projections (2015-2026) 2.4.4 Japan Neuroleptic Estimates and Projections (2015-2026) 2.4.5 Southeast Asia Neuroleptic Estimates and Projections (2015-2026) 2.4.6 India Neuroleptic Estimates and Projections (2015-2026) 3 Global Neuroleptic Competition Landscape by Players 3.1 Global Top Neuroleptic Players by Sales (2015-2020) 3.2 Global Top Neuroleptic Players by Revenue (2015-2020) 3.3 Global Neuroleptic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroleptic as of 2019) 3.4 Global Neuroleptic Average Price by Company (2015-2020) 3.5 Manufacturers Neuroleptic Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3.7 Primary Interviews with Key Neuroleptic Players (Opinion Leaders) 4 Global Neuroleptic Market Size by Type 4.1 Global Neuroleptic Historic Market Review by Type (2015-2020) 4.1.1 Global Neuroleptic Sales Market Share by Type (2015-2020) 4.1.2 Global Neuroleptic Revenue Market Share by Type (2015-2020) 4.1.3 Global Neuroleptic Price by Type (2015-2020) 4.2 Global Neuroleptic Market Estimates and Forecasts by Type (2021-2026) 4.2.1 Global Neuroleptic Sales Forecast by Type (2021-2026) 4.2.2 Global Neuroleptic Revenue Forecast by Type (2021-2026) 4.2.3 Global Neuroleptic Price Forecast by Type (2021-2026) 5 Global Neuroleptic Market Size by Application 5.1 Global Neuroleptic Historic Market Review by Application (2015-2020) 5.1.1 Global Neuroleptic Sales Market Share by Application (2015-2020) 5.1.2 Global Neuroleptic Revenue Market Share by Application (2015-2020) 5.1.3 Global Neuroleptic Price by Application (2015-2020) 5.2 Global Neuroleptic Market Estimates and Forecasts by Application (2021-2026) 5.2.1 Global Neuroleptic Sales Forecast by Application (2021-2026) 5.2.2 Global Neuroleptic Revenue Forecast by Application (2021-2026) 5.2.3 Global Neuroleptic Price Forecast by Application (2021-2026) 6 United States Neuroleptic Market Facts & Figures 6.1 United States Neuroleptic Sales Market Share by Company (2015-2020) 6.2 United States Neuroleptic Sales Market Share by Type (2015-2020) 6.3 United States Neuroleptic Sales Market Share by Application (2015-2020) 7 Europe Neuroleptic Market Facts & Figures 7.1 Europe Neuroleptic Sales Market Share by Company (2015-2020) 7.2 Europe Neuroleptic Sales Market Share by Type (2015-2020) 7.3 Europe Neuroleptic Sales Market Share by Application (2015-2020) 8 China Neuroleptic Market Facts & Figures 8.1 China Neuroleptic Sales Market Share by Company (2015-2020) 8.2 China Neuroleptic Sales Market Share by Type (2015-2020) 8.3 China Neuroleptic Sales Market Share by Application (2015-2020) 9 Japan Neuroleptic Market Facts & Figures 9.1 Japan Neuroleptic Sales Market Share by Company (3015-3030) 9.2 Japan Neuroleptic Sales Market Share by Type (2015-2020) 9.3 Japan Neuroleptic Sales Market Share by Application (2015-2020) 10 Southeast Asia Neuroleptic Market Facts & Figures 10.1 Southeast Asia Neuroleptic Sales Market Share by Company (2015-2020) 10.2 Southeast Asia Neuroleptic Sales Market Share by Type (2015-2020) 10.3 Southeast Asia Neuroleptic Sales Market Share by Application (2015-2020) 11 India Neuroleptic Market Facts & Figures 11.1 India Neuroleptic Sales Market Share by Company (2015-2020) 11.2 India Neuroleptic Sales Market Share by Type (2015-2020) 11.3 India Neuroleptic Sales Market Share by Application (2015-2020) 12 Company Profiles and Key Figures in Neuroleptic Business 12.1 Johnson & Johnso 12.1.1 Johnson & Johnso Corporation Information 12.1.2 Johnson & Johnso Business Overview 12.1.3 Johnson & Johnso Neuroleptic Sales, Revenue and Gross Margin (2015-2020) 12.1.4 Johnson & Johnso Neuroleptic Products Offered 12.1.5 Johnson & Johnso Recent Development 12.2 Pfizer 12.2.1 Pfizer Corporation Information 12.2.2 Pfizer Business Overview 12.2.3 Pfizer Neuroleptic Sales, Revenue and Gross Margin (2015-2020) 12.2.4 Pfizer Neuroleptic Products Offered 12.2.5 Pfizer Recent Development 12.3 Eli Lilly 12.3.1 Eli Lilly Corporation Information 12.3.2 Eli Lilly Business Overview 12.3.3 Eli Lilly Neuroleptic Sales, Revenue and Gross Margin (2015-2020) 12.3.4 Eli Lilly Neuroleptic Products Offered 12.3.5 Eli Lilly Recent Development 12.4 Bristol-Myers Squibb 12.4.1 Bristol-Myers Squibb Corporation Information 12.4.2 Bristol-Myers Squibb Business Overview 12.4.3 Bristol-Myers Squibb Neuroleptic Sales, Revenue and Gross Margin (2015-2020) 12.4.4 Bristol-Myers Squibb Neuroleptic Products Offered 12.4.5 Bristol-Myers Squibb Recent Development 12.5 GlaxoSmithKline 12.5.1 GlaxoSmithKline Corporation Information 12.5.2 GlaxoSmithKline Business Overview 12.5.3 GlaxoSmithKline Neuroleptic Sales, Revenue and Gross Margin (2015-2020) 12.5.4 GlaxoSmithKline Neuroleptic Products Offered 12.5.5 GlaxoSmithKline Recent Development ... 13 Neuroleptic Manufacturing Cost Analysis 13.1 Neuroleptic Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Neuroleptic 13.4 Neuroleptic Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Neuroleptic Distributors List 14.3 Neuroleptic Customers 15 Market Dynamics 15.1 Neuroleptic Market Trends 15.2 Neuroleptic Opportunities and Drivers 15.3 Neuroleptic Market Challenges 15.4 Neuroleptic Market Restraints 15.5 Porter's Five Forces Analysis 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Neuroleptic Sales (MT) Growth Rate by Type (2020-2026) (US$ Million) Table 2. Global Neuroleptic Sales (MT) Comparison by Application (2020-2026) (US$ Million) Table 3. Global Market Neuroleptic Market Size (US$ Million) by Region:2015 VS 2020 &2026 Table 4. Global Neuroleptic Sales (MT) by Region (2015-2020) Table 5. Global Neuroleptic Sales Market Share by Region (2015-2020) Table 6. Global Neuroleptic Revenue (US$ Million) Market Share by Region (2015-2020)) Table 7. Global Neuroleptic Revenue Share by Region (2015-2020) Table 8. Global Neuroleptic Sales (MT) Forecast by Region (2021-2026) Table 9. Global Neuroleptic Sales Market Share Forecast by Region (2021-2026) Table 10. Global Neuroleptic Revenue (US$ Million) Forecast by Region (2021-2026) Table 11. Global Neuroleptic Revenue Share Forecast by Region (2021-2026) Table 12. Global Neuroleptic (MT) of Key Companies (2015-2020) Table 13. Global Neuroleptic Sales Share by Company (2015-2020) Table 14. Global Neuroleptic Revenue (US$ Million) by Company (2015-2020) Table 15. Global Neuroleptic Revenue Share by Company (2015-2020) Table 16. Global Neuroleptic by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroleptic as of 2019) Table 17. Global Neuroleptic Average Price (USD/MT) of Key Company (2015-2020) Table 18. Manufacturers Neuroleptic Manufacturing Sites and Area Served Table 19. Manufacturers Neuroleptic Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Main Points Interviewed from Key Neuroleptic Players Table 22. Global Neuroleptic Sales (MT) by Type (2015-2020) Table 23. Global Neuroleptic Sales Share by Type (2015-2020) Table 24. Global Neuroleptic Revenue (US$ Million) Market Share by Type (2015-2020) Table 25. Global Neuroleptic Price (MT) by Type (2015-2020) Table 26. Global Neuroleptic Sales Share by Type (2021-2026) Table 27. Global Neuroleptic Revenue (US$ Million) Market Share by Type (2021-2026) Table 28. Global Neuroleptic Revenue Share by Type (2021-2026) Table 29. Global Neuroleptic Price (MT) by Type (2021-2026) Table 30. Global Neuroleptic Sales (MT) by Application (2015-2020) Table 31. Global Neuroleptic Sales Share by Application (2015-2020) Table 32. Global Neuroleptic Revenue (US$ Million) Market Share by Application (2015-2020) Table 33. Global Neuroleptic Price (MT) by Application (2015-2020) Table 34. Global Neuroleptic Sales (MT) by Application (2021-2026) Table 35. Global Neuroleptic Sales Share by Application (2021-2026) Table 36. Global Neuroleptic Revenue (US$ Million) Market Share by Application (2021-2026) Table 37. Global Neuroleptic Revenue Share by Application (2021-2026) Table 38. Global Neuroleptic Price (MT) by Application (2021-2026) Table 39. United States Neuroleptic Sales (MT) by Company (2015-2020) Table 40. United States Neuroleptic Sales Market Share by Company (2015-2020) Table 41. United States Neuroleptic Sales (MT) by Type (2015-2020) Table 42. United States Neuroleptic Sales Market Share by Type (2015-2020) Table 43. United States Neuroleptic Sales (MT) by Application (2015-2020) Table 44. United States Neuroleptic Sales Market Share by Application (2015-2020) Table 45. Europe Neuroleptic Sales (MT) by Company (2015-2020) Table 46. Europe Neuroleptic Sales Market Share by Company (2015-2020) Table 47. Europe Neuroleptic Sales (MT) by Type (2015-2020) Table 48. Europe Neuroleptic Sales Market Share by Type (2015-2020) Table 49. Europe Neuroleptic Sales (MT) by Application (2015-2020) Table 50. Europe Neuroleptic Sales Market Share by Type (2015-2020) Table 51. China Neuroleptic Sales (MT) by Company (2015-2020) Table 52. China Neuroleptic Sales Market Share by Company (2015-2020) Table 53. China Neuroleptic Sales (MT) by Type (2015-2020) Table 54. China Neuroleptic Sales Market Share by Type (2015-2020) Table 55. China Neuroleptic Sales (MT) by Application (2015-2020) Table 56. China Neuroleptic Sales Market Share by Application (2015-2020) Table 57. Japan Neuroleptic Sales (MT) by Company (2015-2020) Table 58. Japan Neuroleptic Sales Market Share by Company (2015-2020) Table 59. Japan Neuroleptic Sales (MT) by Type (2015-2020) Table 60. Japan Neuroleptic Sales Market Share by Type (2015-2020) Table 61. Japan Neuroleptic Sales (MT) by Application (2015-2020) Table 62. Japan Neuroleptic Sales Market Share by Application (2015-2020) Table 63. Southeast Asia Neuroleptic Sales (MT) by Company (2015-2020) Table 64. Southeast Asia Neuroleptic Sales Market Share by Company (2015-2020) Table 65. Southeast Asia Neuroleptic Sales (MT) by Type (2015-2020) Table 66. Southeast Asia Neuroleptic Sales Market Share by Type (2015-2020) Table 67. Southeast Asia Neuroleptic Sales (MT) by Type (2015-2020) Table 68. Southeast Asia Neuroleptic Sales Market Share by Application (2015-2020) Table 69. India Neuroleptic Sales (MT) by Company (2015-2020) Table 70. India Neuroleptic Sales Market Share by Company (2015-2020) Table 71. India Neuroleptic Sales (MT) by Type (2015-2020) Table 72. India Neuroleptic Sales Market Share by Type (2015-2020) Table 73. India Neuroleptic Sales (MT) by Application (2015-2020) Table 74. India Neuroleptic Sales Market Share by Application (2015-2020) Table 75. Johnson & Johnso Corporation Information Table 76. Johnson & Johnso Description and Business Overview Table 77. Johnson & Johnso Neuroleptic Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 78. Johnson & Johnso Neuroleptic Product Table 79. Johnson & Johnso Recent Development Table 80. Pfizer Corporation Information Table 81. Pfizer Description and Business Overview Table 82. Pfizer Neuroleptic Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 83. Pfizer Neuroleptic Product Table 84. Pfizer Recent Development Table 85. Eli Lilly Corporation Information Table 86. Eli Lilly Description and Business Overview Table 87. Eli Lilly Neuroleptic Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 88. Eli Lilly Neuroleptic Product Table 89. Eli Lilly Recent Development Table 90. Bristol-Myers Squibb Corporation Information Table 91. Bristol-Myers Squibb Description and Business Overview Table 92. Bristol-Myers Squibb Neuroleptic Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 93. Bristol-Myers Squibb Neuroleptic Product Table 94. Bristol-Myers Squibb Recent Development Table 95. GlaxoSmithKline Corporation Information Table 96. GlaxoSmithKline Description and Business Overview Table 97. GlaxoSmithKline Neuroleptic Sales (MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020) Table 98. GlaxoSmithKline Neuroleptic Product Table 99. GlaxoSmithKline Recent Development Table 100. Production Base and Market Concentration Rate of Raw Material Table 101. Key Suppliers of Raw Materials Table 102. Neuroleptic Distributors List Table 103. Neuroleptic Customers List Table 104. Neuroleptic Market Key Trends Table 105. Neuroleptic Key Opportunities and Drivers Table 106. Neuroleptic Market Challenges Table 107. Research Programs/Design for This Report Table 108. Key Data Information from Secondary Sources Table 109. Key Data Information from Primary Sources List of Figures Figure 1. Neuroleptic Product Picture Figure 2. Global Neuroleptic Sales Market Share by Type in 2020 & 2026 Figure 3. Type I Product Picture Figure 4. Type II Product Picture Figure 5. Global Neuroleptic Market Share by Application in 2020 & 2026 Figure 6. Medical Care Examples Figure 7. Scientific Research Examples Figure 8. Others Examples Figure 9. Global Neuroleptic Sales (MT) Growth Rate (2015-2026) Figure 10. Global Neuroleptic Revenue (US$ Million) Growth Rate (2015-2026) Figure 11. Global Neuroleptic Price Trends Growth Rate (2015-2026) (USD/MT) Figure 12. Global Neuroleptic Revenue Market Share by Region: 2015 VS 2020 Figure 13. Global Neuroleptic Revenue Market Share by Region: 2021 VS 2026 Figure 14. United States Neuroleptic Revenue (Million USD) Growth Rate (2015-2026) Figure 15. United States Neuroleptic Sales (MT) Growth Rate (2015-2026) Figure 16. Europe Neuroleptic Revenue (Million USD) Growth Rate (2015-2026) Figure 17. Europe Neuroleptic Sales (Million USD) Growth Rate (2015-2026) Figure 18. China Neuroleptic Revenue (Million USD) Growth Rate (2015-2026) Figure 19. China Neuroleptic Sales (Million USD) and Growth Rate (2015-2026) Figure 20. Japan Neuroleptic Revenue (Million USD) Growth Rate (2015-2026) Figure 21. Japan Neuroleptic Sales (Million USD) Growth Rate (2015-2026) Figure 22. Southeast Asia Neuroleptic Revenue (Million USD) Growth Rate (2015-2026) Figure 23. Southeast Asia Neuroleptic Sales (Million USD) Growth Rate (2015-2026) Figure 24. India Neuroleptic Revenue (Million USD) Growth Rate (2015-2026) Figure 25. India Neuroleptic Sales (Million USD) Growth Rate (2015-2026) Figure 26. Global 5 Largest Neuroleptic Players Market Share by Revenue in Neuroleptic 2015 & 2019 Figure 27. Neuroleptic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 28. Global Neuroleptic Revenue Share by Type (2015-2020) Figure 29. Global Neuroleptic Revenue Growth Rate by Type in 2015 & 2019 Figure 30. Global Neuroleptic Revenue Share by Application (2015-2020) Figure 31. Global Neuroleptic Revenue Growth Rate by Application in 2015 & 2019 Figure 32. United States Neuroleptic Sales Market Share by Type in 2019 Figure 33. United States Neuroleptic Sales Market Share by Type in 2019 Figure 34. Europe Neuroleptic Sales Market Share by Company in 2019 Figure 35. Europe Neuroleptic Sales Market Share by Type in 2019 Figure 36. Europe Neuroleptic Sales Market Share by Application in 2019 Figure 37. China Neuroleptic Sales Market Share by Company in 2019 Figure 38. China Neuroleptic Sales Market Share by Type in 2019 Figure 39. China Neuroleptic Sales Market Share by Application in 2019 Figure 40. Japan Neuroleptic Sales Market Share by Company in 2019 Figure 41. Japan Neuroleptic Sales Market Share by Type in 2019 Figure 42. Japan Neuroleptic Sales Market Share by Application in 2019 Figure 43. Southeast Asia Neuroleptic Sales Market Share by Company in 2019 Figure 44. Southeast Asia Neuroleptic Sales Market Share by Type in 2019 Figure 45. Southeast Asia Neuroleptic Sales Market Share by Application in 2019 Figure 46. India Neuroleptic Sales Market Share by Company in 2019 Figure 47. India Neuroleptic Sales Market Share by Type in 2019 Figure 48. India Neuroleptic Sales Market Share by Application in 2019 Figure 49. Key Raw Materials Price Trend Figure 50. Manufacturing Cost Structure of Neuroleptic Figure 51. Manufacturing Process Analysis of Neuroleptic Figure 52. Neuroleptic Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Porter's Five Forces Analysis Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed

Johnson & Johnso Pfizer Eli Lilly Bristol-Myers Squibb GlaxoSmithKline